Published in Inf Dent on March 08, 1990
Sialendoscopy in juvenile recurrent parotitis: a review of the literature. Acta Otorhinolaryngol Ital (2013) 0.83
Response to "Interventional sialendoscopy for treatment of juvenile recurrent parotitis". J Indian Assoc Pediatr Surg (2012) 0.75
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med (1983) 8.26
The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med (1978) 7.17
A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors. Nature (1987) 3.00
Reorganizing an academic medical service: impact on cost, quality, patient satisfaction, and education. JAMA (1998) 2.53
Health service use among low-risk newborns after early discharge with and without nurse home visiting. J Am Board Fam Pract (1997) 1.97
Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med (1979) 1.87
Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med (1982) 1.83
Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell (1990) 1.80
Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase. Nature (1995) 1.79
A new immunodeficiency disorder in humans involving NK cells. Nature (1980) 1.78
Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA (1991) 1.77
NIH conference. Recent advances in chronic granulomatous disease. Ann Intern Med (1983) 1.76
Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. J Clin Invest (1988) 1.56
The effect of cyclosporine on the use of hospital resources for kidney transplantation. N Engl J Med (1989) 1.49
Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes. J Clin Invest (1980) 1.43
Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function. J Exp Med (1980) 1.41
The North American Conference of GI Fellows: medicine and the pharmaceutical industry at its best. Am J Gastroenterol (1994) 1.38
Mechanisms of human cell-mediated cytotoxicity. III. Dependence of natural killing on microtubule and microfilament integrity. J Immunol (1982) 1.37
The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res (1997) 1.37
Test-retest performance of a mailed version of the Medical Outcomes Study 36-Item Short-Form Health Survey among older adults. Med Care (1996) 1.36
Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2011) 1.26
Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis. Clin Exp Immunol (1978) 1.25
Diet therapy for rheumatoid arthritis. Arthritis Rheum (1983) 1.21
Work disability among adults with asthma. Chest (1993) 1.20
Human blood monocytes: characterization of negatively selected human monocytes and their suspension cell culture derivatives. Scand J Immunol (1981) 1.19
Increased risk of neisserial infections in systemic lupus erythematosus. Semin Arthritis Rheum (1990) 1.11
Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event. J Immunol (1982) 1.09
Immunoregulation in infection caused by Mycobacterium tuberculosis: the presence of suppressor monocytes and the alteration of subpopulations of T lymphocytes. J Infect Dis (1979) 1.08
Autologous and allogeneic intercellular interactions: modulation by adherent cells, irradiation, and in vitro and in vivo corticosteroids. J Immunol (1979) 1.04
Alteration of T-lymphocyte subpopulations in sarcoidosis. Clin Immunol Immunopathol (1978) 1.03
Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis. Arthritis Rheum (2009) 1.03
Mechanisms of human cell-mediated cytotoxicity. I. Modulation of natural killer cell activity by cyclic nucleotides. J Immunol (1982) 1.02
Association of Wegener's granulomatosis with HLA-B8. Clin Immunol Immunopathol (1979) 1.02
Scleroderma esophagus: a nonspecific entity. Ann Intern Med (1984) 1.02
Rheumatoid vasculitis: experience with 13 patients and review of the literature. Semin Arthritis Rheum (1985) 0.97
Rheumatoid-like arthritis presenting as idiopathic pulmonary hemosiderosis: a report and review of the literature. J Rheumatol (1986) 0.97
Psychiatric consultation in the nursing home. A survey of six states. Am J Geriatr Psychiatry (1998) 0.96
Are pressure ulcers preventable? A survey of experts. Adv Skin Wound Care (2002) 0.95
Use of an electronic stimulator for the treatment of dry mouth. J Oral Maxillofac Surg (1986) 0.94
[Endoscopy of the salivary glands]. Ann Radiol (Paris) (1991) 0.91
Ectopic pregnancy in the United States: economic consequences and payment source trends. Obstet Gynecol (1993) 0.90
Mechanisms of corticosteroid action on lymphocyte subpopulations. V. Effects of in vivo hydrocortisone on the circulatory kinetics and function of naturally occuring and mitogen-induced suppressor cells in man. Cell Immunol (1979) 0.90
Life-threatening bacterial pneumonia in male homosexuals with laboratory features of the acquired immunodeficiency syndrome. Chest (1985) 0.89
Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay. J Clin Invest (1982) 0.89
Assessment of the diet of patients with rheumatoid arthritis and osteoarthritis. J Am Diet Assoc (1983) 0.89
Colonic necrosis complicating postoperative pancreatitis. Ann Surg (1974) 0.88
Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Am Heart J (1996) 0.86
Tryptophan-associated eosinophilic connective-tissue disease. A new clinical entity? JAMA (1990) 0.85
Serum angiotensin-converting enzyme and lysozyme in granulomatous diseases of unknown cause. Ann Intern Med (1981) 0.85
An anterior transversalis fascia repair for adult inguinal hernias. Am J Surg (1978) 0.85
Dyspnea and pulmonary function in the L-tryptophan-associated eosinophilia-myalgia syndrome. Chest (1992) 0.85
In vitro immunoglobulin production by mononuclear cells in rheumatoid arthritis. Clin Immunol Immunopathol (1983) 0.84
Achalasia: two effective treatment options--let the patient decide. Am J Gastroenterol (1994) 0.82
Small bowel obstruction as a complication of disseminated varicella-zoster infection. Surgery (1978) 0.82
Immunosuppressant therapy. Adv Intern Med (1984) 0.82
Technetium pyrophosphate muscle scans in inflammatory muscle disease. Br J Rheumatol (1987) 0.81
Characterization of corticosteroid receptors in natural killer cells: comparison with circulating lymphoid and myeloid cells. Cell Immunol (1985) 0.81
The Overlap Between Fibromyalgia and Inflammatory Rheumatic Disease: When and Why Does it Occur? J Clin Rheumatol (1995) 0.81
Mechanisms of human cell-mediated cytotoxicity. II. Correction of the selective defect in natural killing in the Chediak-Higashi syndrome with inducers of intracellular cyclic GMP. J Immunol (1982) 0.80
The effects of corticosteroids on immunoregulation in sarcoidosis. Cell Immunol (1979) 0.80
Selecting a generic measure of health-related quality of life for use among older adults. A comparison of candidate instruments. Eval Health Prof (1998) 0.80
Anticentromere antibody is not specific for connective tissue disease with a promising prognosis. Arthritis Rheum (1985) 0.79
IgM rheumatoid factor elaboration by blood, bone marrow, and synovial mononuclear cells in patients with rheumatoid arthritis. Clin Immunol Immunopathol (1985) 0.79
Self-image disparity: a developmental approach. J Pers Soc Psychol (1967) 0.79
Rheumatoid vasculitis: diagnostic and therapeutic decisions. Clin Rheumatol (1983) 0.79
[Extracorporeal shockwave lithotripsy (ESWL) for salivary gland stones: a retrospective study of 1571 patients]. Rev Stomatol Chir Maxillofac (2011) 0.79
Lack of generation of killer cells in the mixed lymphocyte reaction between mitogen-stimulated and unstimulated autologous lymphocytes. J Immunol (1978) 0.79
Mortality risk among elderly workers. Am J Ind Med (1994) 0.78
Therapeutic strategies in autoimmune disease: cyclosporin A as a model agent. In Vivo (1992) 0.78
Immune responses of human lymphocytes in vitro. Prog Clin Immunol (1980) 0.78
Eosinophilia-myalgia syndrome not associated with the ingestion of nutritional supplements. J Rheumatol (1994) 0.78
The effects of in vivo hydrocortisone on lymphocyte-mediated cytotoxicity. Arthritis Rheum (1984) 0.78
Clinical and laboratory evaluation of the immune system. Med Clin North Am (1985) 0.78
A national study of medical care expenditures for respiratory conditions. Eur Respir J (2002) 0.78
Tenidap in patients with rheumatoid arthritis. A 4-week, placebo-controlled study. Scand J Rheumatol (1996) 0.77
Differences in activity limitation, pain intensity, and global health in patients with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up. Scand J Rheumatol (2011) 0.77
A course on teaching for house officers. J Med Educ (1985) 0.77
The immunologic effects, kinetics, and use of glucocorticosteroids. Med Clin North Am (1985) 0.77
[New applications of echography in maxillo-facial pathology]. Inf Dent (1990) 0.77
Modulation of certain immunologic responses by vitamin C. III. Potentiation of in vitro and in vivo lymphocyte responses. Int J Vitam Nutr Res Suppl (1982) 0.77
Purification of human monocyte-macrophages by a cell suspension culture technique. Cell Immunol (1980) 0.77
Telescoping anastomosis of the colon: a comparative study. Dis Colon Rectum (1979) 0.76
Deficient expression in multiple sclerosis of the inhibitory transcription factor Sp3 in mononuclear blood cells. Ann Neurol (1996) 0.76
In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome. J Immunol (1984) 0.76
Growth hormone releasing factor and somatostatin concentrations in the milk of lactating women. Eur J Pediatr (1988) 0.76
"Living again": heterogeneous support group for transplant patients and their families. Transplant Proc (2001) 0.76
Detection of Duchenne muscular dystrophy carriers: quantitative echography and creatine kinasemia. Hum Genet (1987) 0.76
Bronchiolitis obliterans organizing pneumonia associated with essential mixed cryoglobulinemia. Arthritis Rheum (1993) 0.76
Nocardia asteroides sinusitis. Presentation as a trimethoprim-sulfamethoxazole responsive fever of unknown origin. JAMA (1977) 0.75
Use of cyclosporin A in the eosinophilia myalgia syndrome. Ann Rheum Dis (1993) 0.75
Serum cytokines and the eosinophilia myalgia syndrome. Ann Intern Med (1992) 0.75
Antibody-dependent cellular cytotoxicity mediated by subpopulations of human T lymphocytes: killing of human erythrocytes and autologous lymphoid cells. Immunology (1980) 0.75
[The Coanda effect]. Gesund Ing (1973) 0.75
Dynamics and treatment of foster children. Can Psychiatr Assoc J (1968) 0.75
Detection and quantitation of circulating immune complexes in arterial blood of patients with rheumatic disease. Clin Immunol Immunopathol (1985) 0.75
Relationship between pacemaker fibrillation thresholds and electrode area. Med Instrum (1975) 0.75
[Amoxicillin in odonto-stomatology]. Chir Dent Fr (1977) 0.75
[Systematic antibiotic therapy in question: should antibiotics be prescribed after extraction of the wisdom teeth?]. Actual Odontostomatol (Paris) (1977) 0.75
Progressive muscular dystrophy. Functional improvement after a renal allograft. J Neurol Sci (1976) 0.75
The therapy of adolescent schizophrenia. Am J Psychiatry (1970) 0.75